More recently, genetic profiling of fatty acid desaturase 2 (FADS2) polymorphisms has been shown to identify patients who may benefit from high-dose omega-3 PUFAs for cardiac remodeling after acute myocardial infarction (193). The gene discussed is FADS2; the disease is acute myocardial infarction.